跳到正文

Kotler Kevin 13F 持仓 · 最近申报 2025年Q4

Kotler Kevin 在 2025年Q4(报告期截至 2025-12-31)的 SEC 13F 申报中报告了 34 只证券,申报市值合计 4.27 亿美元。前几大持仓:SPY(55.83%)、AVDL(8.17%)、QQQ(7.18%)。本季前 25 大持仓中:新建仓 25 只。

排名代码公司市值占组合股数变动
1SPYSPDR S&P 500 ETF TR$238.7M55.83%350,000新建仓
2AVDLAVADEL PHARMACEUTICALS PLC$34.9M8.17%1.6M新建仓
3QQQINVESCO QQQ TR$30.7M7.18%50,000新建仓
4ANGOANGIODYNAMICS INC$22.0M5.15%1.7M新建仓
5AUPHAURINIA PHARMACEUTICALS INC$19.5M4.57%1.2M新建仓
6OMEROMEROS CORP$19.3M4.53%1.1M新建仓
7NPCENEUROPACE INC$9.7M2.28%631,468新建仓
8MDWDMEDIWOUND LTD$6.2M1.46%337,236新建仓
9AXGNAXOGEN INC$5.5M1.29%168,000新建仓
10IARTINTEGRA LIFESCIENCES HLDGS C$5.3M1.24%427,445新建仓
11ACRSACLARIS THERAPEUTICS INC$5.1M1.20%1.7M新建仓
12EVTLVERTICAL AEROSPACE LTD$5.0M1.17%939,705新建仓
13OSURORASURE TECHNOLOGIES INC$4.4M1.02%1.8M新建仓
14LKFTGALAPAGOS NV$2.9M0.69%90,000新建仓
15LLYELI LILLY & CO$2.1M0.50%2,000新建仓
16CERSCERUS CORP$2.1M0.49%1.0M新建仓
17NKENIKE INC$2.0M0.48%32,000新建仓
18TECXTECTONIC THERAPEUTIC INC$1.7M0.39%80,000新建仓
19CLYMCLIMB BIO INC$1.6M0.37%400,000新建仓
20TMCITREACE MED CONCEPTS INC$1.2M0.27%474,365新建仓
21TLSITRISALUS LIFE SCIENCES INC$1.0M0.24%145,200新建仓
22DXCMDEXCOM INC$995,5500.23%15,000新建仓
23VNDAVANDA PHARMACEUTICALS INC$882,0000.21%100,000新建仓
24ALGNALIGN TECHNOLOGY INC$680,6580.16%4,359新建仓
25OKURONKURE THERAPEUTICS INC$573,3040.13%197,691新建仓

来源:SEC 13F 申报文件 · 截至 2025-12-31

本期 13F-HR 中的全部持仓,以及相对上季度的变化。

13F 持仓,最新季度

来源SEC EDGAR13F-HR